New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis
Christophe Duret,1 Nathalie Wauthoz,1 Thami Sebti,2 Francis Vanderbist,2 Karim Amighi11Laboratoire de Pharmacie Galénique et de Biopharmacie, Université Libre de Bruxelles, Brussels, Belgium; 2SMB Laboratoires, Brussels, BelgiumPurpose: Itraconazole (ITZ) dry powders fo...
Guardado en:
Autores principales: | Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8c277d50ced4dda953e8090747cd924 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ANTI-INFLAMMATORY EFFECT OF ITRACONAZOLE IN PATIENTS WITH ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
por: Y. I. Kozlova, et al.
Publicado: (2018) -
Understanding the Importance of Capsules in Dry Powder Inhalers
por: Francesca Buttini, et al.
Publicado: (2021) -
Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: HF Salem, et al.
Publicado: (2011) -
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols
por: Meenach SA, et al.
Publicado: (2013) -
Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis
por: Jie Gao, et al.
Publicado: (2018)